Aptevo Therapeutics Inc. — Director's Dealing 2017

Jun 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2017-06-01

Reporting Person: Abdun-Nabi Daniel (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	Employee Stock Option (right to buy)	$2.15	A	12500	Acquired	2027-05-31	Common Stock (12500)	Direct

Footnotes

F1: The option vests in three equal annual installments beginning on June 1, 2018.